The strength of this study is that we focused on patients with newly diagnosed T2DM and evaluated the relative contributions of systemic iron status (including SI, SF, Trf, and TS) to pancreatic β-cell function and insulin sensitivity. This evidence concerns the gene INS and type 2 diabetes mellitus.